L Vamvakas Selected Research

L Vamvakas Research Topics

8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017 - 12/2001
7	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 02/2002
7	Neoplasms (Cancer) 11/2011 - 01/2001
6	Neutropenia 03/2017 - 01/2001
6	Breast Neoplasms (Breast Cancer) 01/2015 - 09/2001
3	Diarrhea 03/2017 - 01/2007
3	Disease Progression 01/2016 - 01/2007
3	Febrile Neutropenia 01/2012 - 01/2006
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2010 - 01/2001
2	Nausea 01/2006 - 01/2006
2	Vomiting 01/2006 - 01/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015
1	Adenocarcinoma 04/2015
1	Neoplasm Metastasis (Metastasis) 12/2012
1	Proteinuria 08/2010
1	Esophagitis 06/2010
1	Adenocarcinoma of Lung 01/2009
1	Circulating Neoplastic Cells 05/2007
1	Exanthema (Rash) 01/2007
1	Carcinoma (Carcinomatosis) 11/2006
1	Prostatic Neoplasms (Prostate Cancer) 01/2005
1	Fatigue 01/2001
1	Ovarian Neoplasms (Ovarian Cancer) 01/2001

10	Irinotecan (Camptosar)FDA LinkGeneric 03/2017 - 12/2001
8	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 12/2001
8	Gemcitabine FDA Link 01/2016 - 01/2006
7	Docetaxel (Taxotere)FDA Link 04/2015 - 01/2005
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2012 - 01/2006
6	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 09/2001
6	Leucovorin (Folinic Acid)FDA Link 12/2012 - 09/2001
5	Bevacizumab (Avastin)FDA Link 04/2015 - 08/2010
3	Vinorelbine (Navelbine)FDA LinkGeneric 04/2015 - 01/2006
3	Capecitabine (Xeloda)FDA Link 01/2012 - 02/2007
2	Pemetrexed (MTA)FDA Link 03/2017 - 01/2006
2	Cetuximab (Erbitux)FDA Link 12/2012 - 02/2007
2	liposomal doxorubicin (Doxil)FDA Link 01/2006 - 01/2005
1	PlatinumIBA 03/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	thiamine triphosphorate (TTP)IBA 11/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2010
1	Etoposide (VP 16)FDA LinkGeneric 06/2010
1	Messenger RNA (mRNA)IBA 05/2007
1	ErbB Receptors (EGF Receptor)IBA 02/2007
1	Monoclonal AntibodiesIBA 02/2007
1	Immunoglobulin G (IgG)IBA 02/2007
1	Gefitinib (Iressa)FDA Link 01/2007
1	Aligeron (AS 2)IBA 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	1-dodecylpyridoxal (PLD)IBA 01/2006
1	Hormones (Hormone)IBA 01/2005
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2001
1	AnthracyclinesIBA 09/2001
1	Taxoids (Taxanes)IBA 09/2001
1	EnzymesIBA 01/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2001
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2001

11	Drug Therapy (Chemotherapy) 03/2017 - 09/2001
5	Therapeutics 01/2016 - 01/2001
3	Treatment Delay 01/2006 - 01/2006
2	Salvage Therapy 03/2017 - 01/2008
2	Adjuvant Chemotherapy 05/2007 - 08/2005
1	CP protocol 03/2017
1	capecitabine-irinotecan combination 01/2012
1	Radiotherapy 06/2010
1	Consolidation Chemotherapy 06/2010